Translational Development Acquisition (TDACW) Retained Earnings (2023 - 2026)

Translational Development Acquisition has reported Retained Earnings for 4 years, with the latest figure at -$6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 14.77% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at -$6.8 million (down 14.77% YoY), and the FY2025 full-year result was -$6.5 million, down 16.87% from the prior year.
• Retained Earnings for Q1 2026 stood at -$6.8 million, down from -$6.5 million in the prior quarter.
• The five-year high for Retained Earnings was -$532658.0 in Q4 2023, with the low at -$6.8 million in Q1 2026.
• Historically, Retained Earnings has averaged -$5.4 million across 4 years, with a median of -$6.2 million in 2025.
• Annual changes were most pronounced in 2024 — Retained Earnings slumped 950.96% — and 2026, when it fell 14.77%.
• Translational Development Acquisition's Retained Earnings stood at -$532658.0 in 2023, then tumbled by 950.96% to -$5.6 million in 2024, then decreased by 16.87% to -$6.5 million in 2025, then dropped by 4.3% to -$6.8 million in 2026.
• The last three Retained Earnings figures came in at -$6.8 million (Q1 2026), -$6.5 million (Q4 2025), and -$6.4 million (Q3 2025), per Business Quant data.